Stock Market News 8 hours agoShould You Buy Before the Ex-Dividend Date or Wait? Whether you're a newcomer to the world of dividend stocks or a veteran, the question of whether to buy before the ex-dividend date will always be one to ponder. Buying a dividend stock before the ex-dividend date seems evident since you would be entitled to receive the dividend. However, if you understand what happens when a dividend is distributed, the answer gets more involved. New dividend investors mistakenly believe that a dividend is a free money for shareholders. It's a way of getting income from holding dividend stocks. That…Read Article 9 hours agoDividends, Short-Term Pain, but Long-Term Gain? Dividend stocks drop by the dividend amount on the ex-dividend date. The stock takes a short-term hit, but the shareholders are compensated in cash on the payout date. If it's a wash, why are there so many dividend investors? Simple. Dividend investors seek income from holding their stocks long-term. They don't feel they lose anything because they are getting paid the dividend, and the short-term price drop will eventually be recovered if they hold the stock long enough. Well, that may only sometimes be the case. Benchmark Indexes Rise…Read Article 5 hours agoCan Carnival Cruise Lines Set Sail For New Highs? Carnival Cruise Lines (NYSE: CCL) has been weathering stormy seas for the last 2 years, but the skies are clearing, and smoother sailing is ahead. The headwinds are not over, but signs within the Q1 earnings report point to a return to normalcy that includes positive cash flow and debt reduction. What this means for investors is a chance to buy this stock at the lowest prices it has seen in 20 years and at an 80% discount to its prepandemic price point. The Bad Times Are Behind Carnival Cruise Lines The signal in the results…Read Article 3 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment Shares of Sanofi (NASDAQ: SNY) were up 10.20% the week ended March 24, while Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) finished with a gain of 9.68%, following promising news about the companies’ jointly developed medication Dupixent. In Phase 3 clinical trials, Dupixent reduced severe flare-ups of chronic obstructive pulmonary disease (COPD) at a far better rate than a placebo. In a joint news release, the companies said, “Dupixent is the first and only biologic to demonstrate a clinically meaningful and highly…Read Article 7 hours agoIf Safety is Your Concern, Then Take a Look at Sandy Spring Bank The market has been selling off bank stocks on fears of contagion stemming from the Silicon Valley Bank implosion and Signature Bank insolvency. Regional banks were the victims of panic selling. After the Credit Suisse Group AG (NYSE: CS) bailout by UBS Securities, there are rumblings of potential troubles at 'too big to fail' Deutsche Bank AG (NYSE: DB) as shares sank another (-5%) in the past week. Investors are rightfully worried about where the next blowup will occur in the banking sector. If safety is your top concern over…Read Article Latest Stock Market News 39 minutes agoHow major US stock indexes fared Monday 3/27/20231 hour agoSouth Dakota gov's veto of cryptocurrency regulations upheld2 hours ago3 High Yields On Breakout Watch With Analyst Tailwinds3 hours agoFed official: SVB itself was main cause of bank's failure3 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment4 hours agoCollapsed Silicon Valley Bank Finds a Buyer4 hours ago3 Financials The Insiders Are Buying 5 hours agoReport: Elon Musk Says Twitter Is Valued At Less Than Half of What He Paid For It Just Days After Sending Frantic Email to Employees at 2:30 A.M.5 hours agoCan Carnival Cruise Lines Set Sail For New Highs? 5 hours agoCold Stone Creamery Employees Quit En Masse After Fellow Worker Loses 3 Fingers on the Job5 hours agoDeath Tolls Rises Following Chocolate Factory Explosion6 hours agoChatGPT Just Got a Game-Changing Update — Here's What to Know Free Email Newsletter Sign up to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter: Your Email Address Sector Performance Ad Vector VestFree Stock Analysis Report: See The True Value of Any StockGet a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. Analyze Any Stock Free Popular Articles1+ days ago | March 22nd | 2023 7:00AM3 Dividend Contenders to Buy Now for Long-Term Gains Later1+ days agoMullen Automotive: Investment? No. Compelling Speculation, Yes 1+ days agoWhy Wall Street Loves These 3 Penny Stocks1+ days ago3 Tech Stocks Well Positioned For Growth At A Reasonable Price 1+ days ago5 Best Dividend Capture Stocks Stock Ideas2 hours ago | March 27th | 2023 2:30PM3 High Yields On Breakout Watch With Analyst Tailwinds3 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment5 hours agoCan Carnival Cruise Lines Set Sail For New Highs? 7 hours agoIf Safety is Your Concern, Then Take a Look at Sandy Spring Bank7 hours agoBioNTech Is Ripe For A Rebound In 2023 Instant Alerts3 hours ago | March 27th | 2023 1:35PMBank Pictet & Cie Asia Ltd. Boosts Stock Holdings in McDonald's Co. (NYSE:MCD)3 hours agoBank Pictet & Cie Asia Ltd. Acquires 730 Shares of PepsiCo, Inc. (NASDAQ:PEP)3 hours agoPermit Capital LLC Acquires New Position in Meta Platforms, Inc. (NASDAQ:META)3 hours agoFirst Horizon Advisors Inc. Sells 5,724 Shares of The TJX Companies, Inc. (NYSE:TJX)3 hours agoRovida Advisors Inc. Invests $11.96 Million in The Walt Disney Company (NYSE:DIS)3 hours agoValero Energy Co. (NYSE:VLO) Shares Sold by Bank of Montreal Can Ad Vector VestFree Stock Analysis Report: See The True Value of Any StockGet a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. Analyze Any Stock Free Popular StocksCompanyCurrent PricePrice ChangeAAPLApple Inc.$158.28-1.23%MSFTMicrosoft Co.$276.38-1.49%METAMeta Platforms, Inc.$202.84-1.54%GOOGLAlphabet Inc.$102.46-2.83%AMZNAmazon.com, Inc.$98.04-0.09%TSLATesla, Inc.$191.810.74%NVDANVIDIA Co.$265.31-0.93%NIONio Inc -$8.93-1.54%BABAAlibaba Group Holding Limited$86.12-0.90%AMDAdvanced Micro Devices, Inc.$96.61-1.37%TAT&T Inc.$18.871.40%FFord Motor$11.520.09%MUMicron Technology, Inc.$59.79-2.24%Follow Stocks Analyst RatingsCompanyBrokerageActionJNCEJounce Therapeutics, Inc.Piper SandlerDowngradeto NeutralVISLVislink Technologies, Inc.Alliance Global PartnersLower Price Target$1.25 ➝ $1.00CHWYChewy, Inc.CitigroupLower Price Target$43.00 ➝ $36.00DOOOBRP Inc.CitigroupLower Price Target$92.00 ➝ $85.00DRHDiamondRock HospitalityCitigroupLower Price Target$10.00 ➝ $8.00ORAOrmat Technologies, Inc.CitigroupLower Price Target$91.00 ➝ $88.00MNTVMomentive Global Inc.Truist FinancialDowngradeto HoldNVSNovartis AGDeutsche Bank AktiengesellschaftUpgradeto HoldHPHelmerich & Payne, Inc.The Goldman Sachs GroupLower Price Target$44.00 ➝ $38.00VNTVontier Co.The Goldman Sachs GroupBoost Price Target$25.00 ➝ $28.00AMBPArdagh Metal Packaging S.A.Wells Fargo & CompanyLower Price Target$4.80 ➝ $4.25VIRXViracta Therapeutics, Inc.OppenheimerBoost Price Target$14.00 ➝ $16.00See All Analyst Ratings Today's Top GainersCompanyPrice ChangeIndicatorINNVDInnovus Pharmaceuticals Inc143.90%Gap UpEJMLLFantex, Inc.100.00%Gap UpWISAWiSA Technologies, Inc.89.47%Short Interest ↓High Trading VolumeATMSArtemis Therapeutics Inc.69.67%Gap UpCERPQCereplast, Inc.64.65%Gap DownHigh Trading VolumeCUENWCuentas Inc.60.00%Positive NewsGap DownHigh Trading VolumeFCNCAFirst Citizens BancShares, Inc.53.74%Short Interest ↓News CoveragePositive NewsGap UpHigh Trading VolumeLDSILife Design Station International, Inc.53.66%RSTGFThe Restaurant Group plc50.06%Gap UpHigh Trading VolumeSRAXSRAX, Inc.46.31%Gap UpPHGUFPharming Group46.12%Short Interest ↑News CoverageNegative NewsGap UpHigh Trading VolumeLMAOULMF Acquisition Opportunities, Inc.41.59%Gap UpHigh Trading VolumeSee More Top Gainers Today's Top LosersCompanyPrice ChangeIndicatorCDAKCodiak BioSciences, Inc.-56.70%Upcoming EarningsShort Interest ↑News CoverageGap DownTrading HaltedHigh Trading VolumeUBXUnity Biotechnology, Inc.-53.01%News CoverageGap DownTrading HaltedHigh Trading VolumeSPECSpectralCast, Inc.-50.65%Gap DownASCLFAscletis Pharma Inc.-50.21%Gap DownGMDAGamida Cell Ltd.-49.63%Short Interest ↓News CoverageGap DownHigh Trading VolumeHCYTDH-CYTE, Inc.-49.50%Gap DownHigh Trading VolumeEVCIEVCI Career Colleges Holding Corp.-45.61%News CoverageGap DownZURAZura Bio Limited-42.76%Gap UpTrading HaltedHigh Trading VolumeLTONYMNC Media Investment Ltd -42.19%Gap DownHigh Trading VolumeSONNSonnet BioTherapeutics Holdings, Inc.-41.13%Short Interest ↓Positive NewsGap DownHigh Trading VolumeTOROVToro Corp.-37.90%Gap DownDTEADAVIDsTEA Inc.-37.50%Short Interest ↓News CoverageGap DownTrading HaltedHigh Trading VolumeSee More Top Losers × Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.